Aclaris Therapeutics
158 articles about Aclaris Therapeutics
-
Aclaris To Announce First Quarter 2017 Financial Results On May 9, 2017
5/2/2017
-
Aclaris Announces Notice Of Allowance For A U.S. Patent Application Covering Lead Candidate A-101 Topical Solution
4/26/2017
-
Aclaris Announces Notice Of Allowance For Two U.S. Patent Applications Covering Baricitnib And Decernotinib, Respectively, For Hair Loss Disorders
4/4/2017
-
Aclaris Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update
3/15/2017
-
Aclaris Submits New Drug Application For A-101 As A Novel Treatment For Seborrheic Keratosis – A Common Skin Condition
2/27/2017
-
Aclaris To Announce Fourth Quarter And Full Year 2016 Financial Results On March 15, 2017
2/23/2017
-
Aclaris Release: Pharma Announces Appointment Of Andrew Powell To Board Of Directors
1/26/2017
-
Aclaris Initiates Phase I Clinical Trial For ATI-50001, An Investigational JAK Inhibitor, For The Treatment Of Alopecia Totalis And Alopecia Universalis
12/7/2016
-
Aclaris Announces Pricing Of Public Offering Of Common Stock
11/18/2016
-
Aclaris Announces Proposed Public Offering Of Common Stock
11/17/2016
-
Aclaris Announces Positive Top-Line Phase III Results For A-101 In Treating Seborrheic Keratosis, A Common Undertreated Skin Condition
11/16/2016
-
Aclaris Reports Third Quarter 2016 Financial Results
11/3/2016
-
Aclaris Submits Investigational New Drug Application For ATI-50001 To Treat Alopecia Universalis And Alopecia Totalis
10/31/2016
-
Aclaris Honored As One Of The Best Places To Work In Pennsylvania
10/28/2016
-
Aclaris To Announce Third Quarter 2016 Financial Results On November 3, 2016
10/25/2016
-
Aclaris Release: New Observational Study Demonstrates Patient Impact Of Seborrheic Keratosis, A Common, Undertreated Skin Condition Affecting 83.8 Million Americans
10/19/2016
-
Aclaris To Present At The Morgan Stanley 2016 Healthcare Conference
9/6/2016
-
Aclaris Announces Positive Results In Phase II Clinical Trial Of A-101 For Treatment Of Common Warts
8/18/2016
-
Aclaris Reports Second Quarter 2016 Financial Results
8/11/2016
-
Aclaris Announces Appointment Of Bill Humphries To Board Of Directors
8/5/2016